Related Experiment Video
Updated: Mar 26, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
6.6K
Perceptions and Cost-Analysis of a Multiple Mini-Interview in a Pharmacy School Admissions Process.
Robin L Corelli1, Michael A Muchnik2, Ryan J Beechinor1
1Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco.
American Journal of Pharmaceutical Education
|February 4, 2016
Summary
The multiple mini-interview (MMI) format is perceived as effective for doctor of pharmacy admissions interviews by candidates, interviewers, and committee members. This MMI approach also proved more cost-effective than traditional interviews.
Area of Science:
- Pharmacy education
- Admissions assessment
Background:
- Traditional interviews are standard for admissions but may lack efficiency.
- Evaluating the effectiveness and cost of alternative interview formats is crucial.
Purpose of the Study:
- To assess the perceptions of the multiple mini-interview (MMI) format for doctor of pharmacy admissions.
- To compare the cost-effectiveness of the MMI format versus standard interviews.
Main Methods:
- Anonymous web-based surveys were administered to candidates, interviewers, and admissions committee members.
- Perceptions of the MMI format's effectiveness were collected.
- Cost analysis compared resources used in standard interviews (2012) versus MMI (2013).
Main Results:
- A majority of candidates (65%), interviewers (86%), and committee members (79%) found the MMI effective for applicant evaluation.
- Most stakeholders supported continuing the MMI format (candidates 59%, interviewers 84%, committee members 77%).
- Cost per candidate decreased from $136.34 (standard) to $75.30 (MMI).
Conclusions:
- The multiple mini-interview (MMI) format is viewed favorably by all key stakeholder groups in pharmacy admissions.
- The MMI format offers a significant cost reduction per candidate compared to standard interviews.
Related Concept Videos
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
328
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
328
02:16Surveys
17.2K
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
17.2K
01:20Measurement of Bioavailability: Pharmacodynamic Methods
947
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
947
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
652
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
652
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
254
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
254
01:12Analysis of Population Pharmacokinetic Data
905
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
905